期刊文献+

Synthesis and Crystal Structure of Diethyl 5-Acetoxy-3-(4-chlorophenyl)- 4,5-dihydroisoxazol-5-yl-5-phosphonate

Synthesis and Crystal Structure of Diethyl 5-Acetoxy-3-(4-chlorophenyl)- 4,5-dihydroisoxazol-5-yl-5-phosphonate
下载PDF
导出
摘要 The crystal structure of the title compound, diethyl 5-acetoxy-3-(4-chlorophenyl)-4,5- dihydroisoxazol-5-yl-5-phosphonate (C15H19CINO6P, Mr = 375.73), has been synthesized by the treatment of nitrile oxides and l-acetyloxy-vinylphosphonate under very mild conditions in good yields, and determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group C2/c with a = 16.914(10), b = 10.567(7), c = 21.927(13) A, β = 110.249(11)°, V = 3677(4) A^3, Z = 8, Dc = 1.358 g/cm^3, F(000) = 1568,/l(MoKa) = 0.324 mm^-1), S = 1.011, the final R = 0.0661 and wR = 0.1556. The X-ray analytic results showed that the dihedral angle between the phenyl group and the isoxazoline ring is 10.7°. The crystal structure of the title compound, diethyl 5-acetoxy-3-(4-chlorophenyl)-4,5- dihydroisoxazol-5-yl-5-phosphonate (C15H19CINO6P, Mr = 375.73), has been synthesized by the treatment of nitrile oxides and l-acetyloxy-vinylphosphonate under very mild conditions in good yields, and determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group C2/c with a = 16.914(10), b = 10.567(7), c = 21.927(13) A, β = 110.249(11)°, V = 3677(4) A^3, Z = 8, Dc = 1.358 g/cm^3, F(000) = 1568,/l(MoKa) = 0.324 mm^-1), S = 1.011, the final R = 0.0661 and wR = 0.1556. The X-ray analytic results showed that the dihedral angle between the phenyl group and the isoxazoline ring is 10.7°.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2006年第12期1453-1456,共4页 结构化学(英文)
基金 This work was supported by NNSFC (No.20172027)
关键词 crystal structure ISOXAZOLINES PHOSPHONATE synthesis crystal structure, isoxazolines, phosphonate, synthesis
  • 相关文献

参考文献15

  • 1Domingucz,E., Ibcus,E., Matrincz,D., Margota,E., Palacious,J.K., San,M.E.J.Org.Chem.1996,61,5435-5439.
  • 2Buron,C., Kairon,L.E., Hslu,A.Tetrahedron Lett.1997,38,8027-8030.
  • 3Conti,P., Dallanoce,C., Amici,M.D., Micheli,C.D., Klotz,K.N.Bioorg.Med.Chem.1998,6,401-408.
  • 4Mishra,A., Jain,S.K., Asthana,J.G.Orient.J.Chem.1998,14,151-152.
  • 5Ko,D.H., Maponya,M.F., Khalil,M.A., Oriaku,E.T., You,Z., Lee,J.Med.Chem.Res.1998,8,313-324.
  • 6Kang,Y.Y., Shin,K.J., Yoo,K.H., Seo,K.J., Hong,C.Y., Lee,C.S., Park,S.Y., Kim,D.J., Park,S.W.Bioorg.Med.Chem.Lett.2000,10,95-99.
  • 7Tsuge,O., Kanemasa,S., Suga,H.Chem.Lett.1986,183-186.
  • 8Tsuge,O., Kancmasa,S., Suga,H,Chem.Lett.1987,323-326.
  • 9Gi,H.J., Xiang,Y., Schiinazi,R.F., Zhao,K.J.Org.Chem.1997,62,88-92.
  • 10Lee,S.Y., Lee,B.S., Lee,C.W., Oh,D.Y.Synth Commun.1999,29,3621-3626.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部